E-LIB Suche - Ergebnisse für: Newhall, K.

1

NATHALI‐01: A PHASE 1/2A TRIAL OF UCART20X22, AN ALLOGENEIC..:

Bachy, E. ; Ramakrishnan, A. ; Thieblemont, C....
Hematological Oncology. 41 (2023) S2 - p. 825-826 , 2023

Link: https://doi.org/10.1002/..

2

SAFETY AND PRELIMINARY EFFICACY IN PATIENTS WITH RELAPSED/R..:

Wang, M. ; Gordon, L.I. ; Palomba, M.L....
Hematological Oncology. 37 (2019) S2 - p. 301-303 , 2019

Link: https://doi.org/10.1002/..

3

The Structure of Global Attractors for Dissipative Zakharov..:

Erdoğan, M. B. ; Marzuola, J. L. ; Newhall, K..
SIAM Journal on Applied Dynamical Systems. 14 (2015) 4 - p. 1978-1990 , 2015

Link: https://doi.org/10.1137/..

4

Preclinical development ofAMG139, a human antibody specific..:

Köck, K ; Pan, W J ; Gow, J M...
British Journal of Pharmacology. 172 (2014) 1 - p. 159-172 , 2014

Link: https://doi.org/10.1111/..

5

Size-Topology Relations in Packings of Grains, Emulsions, F..:

Newhall, K. A. ; Pontani, L. L. ; Jorjadze, I...
Physical Review Letters. 108 (2012) 26 - p. , 2012

Link: https://doi.org/10.1103/..

6

Safety evaluation and treatment affect of LY2190416, a CB-1..:

NUNAMAKER, E. ; NEWHALL, K. ; THOMPSON, C....
Journal of Veterinary Pharmacology and Therapeutics. 34 (2011) 6 - p. 577-582 , 2011

Link: https://doi.org/10.1111/..

7

CB-1 antagonism with LY2190416 results in acute weight loss..:

NEWHALL, K. ; NUNAMAKER, E. ; GISSENDANNER, S....
Journal of Veterinary Pharmacology and Therapeutics. 33 (2010) 6 - p. 615-618 , 2010

Link: https://doi.org/10.1111/..

8

Nonlinear mixed effects pharmacokinetic/pharmacodynamic ana..:

TERRITO, P. R. ; SHANNON, H. E. ; NEWHALL, K....
Journal of Veterinary Pharmacology and Therapeutics. 31 (2008) 6 - p. 562-570 , 2008

Link: https://doi.org/10.1111/..

9

Development and validation of the maximal electro‐shock sei..:

TERRITO, P. R. ; FREISE, K. J. ; NEWHALL, K....
Journal of Veterinary Pharmacology and Therapeutics. 30 (2007) 6 - p. 508-515 , 2007

Link: https://doi.org/10.1111/..

10

Identification of potential CSF biomarkers in ALS:

Pasinetti, G. M. ; Ungar, L. H. ; Lange, D. J....
Neurology. 66 (2006) 8 - p. 1218-1222 , 2006

Link: https://doi.org/10.1212/..

11

Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS:

Ferrante, K. L. ; Shefner, J. ; Zhang, H....
Neurology. 65 (2005) 11 - p. 1834-1836 , 2005

Link: https://doi.org/10.1212/..

12

Presence of common food allergens in commercially available..:

NEWHALL, K
Journal of Allergy and Clinical Immunology. 113 (2004) 2 - p. S235 , 2004

Link: https://doi.org/10.1016/..

13

Effects of conjugated estrogen on the calcitriol response t..:

Marcus, R ; Villa, M L ; Cheema, M...
The Journal of Clinical Endocrinology & Metabolism. 74 (1992) 2 - p. 413-418 , 1992

Link: https://doi.org/10.1210/..

14

90300684 Effects of estrogen on daylong circulating calcium..:

Packer, E ; Holloway, L ; Newhall, K...
Maturitas. 13 (1991) 2 - p. 172 , 1991

Link: https://doi.org/10.1016/..

15

Pharmacokinetics of spinosad and milbemycin oxime administe..:

HOLMSTROM, S. D. ; TOTTEN, M. L. ; NEWHALL, K. B...
Journal of Veterinary Pharmacology and Therapeutics. 35 (2011) 4 - p. 351-364 , 2011

Link: https://doi.org/10.1111/..